Treatment outcomes of EGFR-TKI with or without locoregional brain therapy in advanced EGFR-mutant non-small cell lung cancer patients with brain metastases

INTRODUCTION: This study aimed to evaluate the treatment outcomes of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy alone or in combination with locoregional brain therapy for advanced EGFR-mutant non-small cell lung cancer (NSCLC) patients with brain metastases. MATER...

Descripción completa

Detalles Bibliográficos
Autores principales: Linh, Do Mai, Thinh, Tran Huy, Hieu, Nguyen-Van, Duc, Nguyen Minh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546967/
https://www.ncbi.nlm.nih.gov/pubmed/37794989
http://dx.doi.org/10.5114/wo.2023.129366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546967/
https://www.ncbi.nlm.nih.gov/pubmed/37794989
http://dx.doi.org/10.5114/wo.2023.129366

Ejemplares similares